Skip to content

Efficacy and safety of interactive digital therapeutics with cognitive behavioral therapy for depressive symptoms in patients with major depressive disorder: A multicenter, randomized, assessor-blinded trial versus an active mood diary control.

Oct 2026 · Journal of Affective Disorders · Vol 417, pp. 122653 · 0 citations · 18 references
Medicine

TL;DR

iDT-CBT showed promising short-term efficacy, although effects on self-reported depressive symptoms were sensitive to the analytical method.

Abstract

INTRODUCTION Digital cognitive behavioral therapy (CBT) is effective for major depressive disorder, but many interventions use static, non-interactive content. Interactive digital therapeutics with CBT (iDT-CBT) provides adaptive, dialogue-based interventions.

Methods

We conducted an 8-week randomized, assessor-blinded trial comparing iDT-CBT with an active mood diary control in 110 adults with major depressive disorder. The primary outcome was change in BDI-II score at Week 8. Secondary outcomes included PHQ-9, MADRS, and BAI. Analyses included all randomized participants, using analysis of covariance adjusted for baseline score and sex.

Results

BDI-II improvement was greater with iDT-CBT than with the active mood diary (13.34 vs. 6.54 points; adjusted p = 0.0003). PHQ-9, MADRS, and BAI improvements also favored iDT-CBT. Week 8 remission proportions were higher with iDT-CBT for BDI-II (30.4% vs. 9.3%), PHQ-9 (62.5% vs. 44.4%), MADRS (23.2% vs. 5.6%), and BAI (50.0% vs. 20.4%). In logistic regression adjusted for baseline score and sex, the conditional odds of remission favored iDT-CBT for all four outcomes (p = 0.011, 0.039, 0.014, and 0.002, respectively), although the unadjusted risk-difference confidence interval for PHQ-9 included zero. However, the BDI-II effect was attenuated in the site-adjusted mixed model for repeated measures (MMRM), and BDI-II and PHQ-9 effects were not significant in MMRM, multiple-imputation, or observed-case analyses. MADRS and BAI remained significant. No adverse-event-related discontinuations or intervention-related serious adverse events occurred.

Discussion

iDT-CBT showed promising short-term efficacy, although effects on self-reported depressive symptoms were sensitive to the analytical method. Longer-term studies are needed. CLINICAL TRIAL REGISTRATION Clinical Research Information Service identifier: KCT0010758 (https://cris.nih.go.kr/cris/search/detailSearch.do?seq=30575).

View source

Similar papers

Open access Oct 2026

Preliminary clinical changes during use of a personalized video-based mobile intervention for community-dwelling individuals with severe mental illness: An exploratory randomized crossover trial

Preliminary findings support further evaluation in larger, adequately powered controlled studies of personalized video-based mobile interventions as a potentially scalable digital–human approach to community-based care for individuals with severe mental illness.

Yongkook Cho, An-Xiao You, Sooin Jeong et al. · 0 citations
Open access Sep 2026

A smartphone-based serious game to improve mental health and medication adherence in adults with depression: A randomised controlled trial.

BACKGROUND Many adults treated with antidepressants experience residual depressive symptoms and low medication adherence. This randomised controlled trial investigated if access to a multicomponent digital intervention including a serious game can improve mental health and medication adherence. METHODS 148 adults wit...

Josefin Brehmer, Matilda Berg, Gabriel Astudillo et al. · 0 citations
Open access Oct 2026

Clinician-guided digital CBT-I improves sleep quality and apnea severity in patients with co-morbid insomnia and OSA: A Double-Blind, Randomized Clinical Trial.

RATIONALE Cognitive behavioral therapy for insomnia (CBT-I) is the accepted first-line treatment for insomnia, but its scalability and safety in patients with co-morbid insomnia and obstructive sleep apnea (COMISA) remain unclear. Clinician-guided digital CBT-I (D-CBT-I) is a potential treatment option that may address...

Yuan Shi, Xu-Jun Feng, Zhao-Hua Chen et al. · 0 citations
Open access Oct 2026

Efficacy of a Prescription-Based Mobile Digital Therapeutic as an Adjunct to Pharmacotherapy for the Acute Phase of Panic Disorder: Multicenter Randomized Controlled Trial

Abstract Background Although pharmacotherapy is the primary treatment for patients with acute-phase panic disorder, its incomplete efficacy causes them to experience frequent panic attacks and severe anticipatory anxiety for a considerable period. A prescription-based mobile digital therapeutic (DTx) that integrates se...

Yu-Jin Ko, Junhyung Kim, Sunyoung Park et al. · 0 citations
Open access Sep 2026

Smartphone-delivered cognitive behavioral therapy for insomnia: A preliminary randomized controlled trial

Study objectives Cognitive behavioral therapy for insomnia (CBT—I) is the first-line treatment for insomnia, but many individuals lack access. This study evaluated the preliminary efficacy of Hvil®, a 9-week, fully automated, smartphone delivered eCBT-I program, in reducing insomnia severity. Methods Adults with insomn...

Sofie M. Ø. Gelberg Knutzen, D. Christensen, Henrike Neumann et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.